Obesity, inflammation and type II diabetes

被引：15

作者：

Finegood, DT ^{[1
]}

机构：

[1] Simon Fraser Univ, Canadian Inst Hlth Res, Inst Nutr Metab & Diabet, Burnaby, BC V5A 1S6, Canada

来源：

关键词：

D O I：

10.1038/sj.ijo.0802490

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S4 / S5

页数：2

共 5 条

[1] ASSESSMENT OF INSULIN SENSITIVITY INVIVO
BERGMAN, RN
FINEGOOD, DT
ADER, M
[J]. ENDOCRINE REVIEWS, 1985, 6 (01) : 45 - 86
[2] β-cell mass dynamics in Zucker diabetic fatty rats -: Rosiglitazone prevents the rise in net cell death
Finegood, DT
McArthur, MD
Kojwang, D
Thomas, MJ
Topp, BG
Leonard, T
Buckingham, RE
[J]. DIABETES, 2001, 50 (05) : 1021 - 1029
[3] ADIPOSE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA - DIRECT ROLE IN OBESITY-LINKED INSULIN RESISTANCE
HOTAMISLIGIL, GS
SHARGILL, NS
SPIEGELMAN, BM
[J]. SCIENCE, 1993, 259 (5091) : 87 - 91
[4] Katzmarzyk PT, 2002, CAN MED ASSOC J, V166, P1039
[5] The spread of the obesity epidemic in the United States, 1991-1998
Mokdad, AH
Serdula, MK
Dietz, WH
Bowman, BA
Marks, JS
Koplan, JP
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16): : 1519 - 1522